| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/06/2006 | CN1829538A Use of substituted 2,4-bis (alkylamino) pyrimidines or -quinazolines as antimicrobials |
| 09/06/2006 | CN1829534A Medicaments for inhalation comprising an anticholinergic and a betamimetic |
| 09/06/2006 | CN1829521A Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 09/06/2006 | CN1829520A Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation |
| 09/06/2006 | CN1829519A Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 09/06/2006 | CN1829518A Compounds, formulations, and methods for treating or preventing rosacea |
| 09/06/2006 | CN1829517A Guanidino-substituted quinazolinone compounds as MC4-R agonists |
| 09/06/2006 | CN1829516A S 2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 09/06/2006 | CN1829515A Use of tripolidine in providing refreshedness on waking |
| 09/06/2006 | CN1829514A CCI-779 lyophilized formulations |
| 09/06/2006 | CN1829513A 5-membered heterocycle-based p-38 inhibitors |
| 09/06/2006 | CN1829512A Medicinal composition containing triazole compound |
| 09/06/2006 | CN1829511A Use of angiotensin II receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 09/06/2006 | CN1829510A Dispersible formulation of an anti-inflammatory agent |
| 09/06/2006 | CN1829509A Combinations of drugs for the treatment of neoplasms |
| 09/06/2006 | CN1829508A Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 09/06/2006 | CN1829507A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 09/06/2006 | CN1829506A Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 09/06/2006 | CN1829505A The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 09/06/2006 | CN1829504A Amino acid composition and supplementary liquid containing the same |
| 09/06/2006 | CN1829503A Veterinary aqueous injectable suspensions containing florfenicol |
| 09/06/2006 | CN1829502A Use of rotigotine for the treatment of depression |
| 09/06/2006 | CN1829501A Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents |
| 09/06/2006 | CN1829499A Method and composition for stable and controlled delivery of (-)-hydroxycitric acid |
| 09/06/2006 | CN1829496A Use of spermine and/or spermidine against skin ageting in dietary, pharmaceutical or cosmetic compositions |
| 09/06/2006 | CN1829489A Preoperative treatment of post operative pain |
| 09/06/2006 | CN1829482A Treatment of dependence withdrawal |
| 09/06/2006 | CN1829453A Alimentation composition and use thereof |
| 09/06/2006 | CN1827776A Method for predicting calcium antagonist medicine effect and application thereof |
| 09/06/2006 | CN1827766A In vitro cell cultivation method |
| 09/06/2006 | CN1827634A Nitrate derivatives of glycyrrhetic acid and glycyrrhetinic acid and pharmaceutical use thereof |
| 09/06/2006 | CN1827632A Process for purifying zidovudine palmitate raw materials and preparations thereof |
| 09/06/2006 | CN1827631A Novel tyrosinase inhibitor and use thereof |
| 09/06/2006 | CN1827629A Glucose phosphonic amide crystals and preparation process and use thereof |
| 09/06/2006 | CN1827627A Novel acyclic nucleoside phosphonic acid and its ester derivatives and pharmaceutical use thereof |
| 09/06/2006 | CN1827621A Novel derivatives and analogues of galanthamin |
| 09/06/2006 | CN1827619A Pyrimidine-5-(1H)-ketone derivative |
| 09/06/2006 | CN1827618A Isoquinoline derivatives and their preparation process and application |
| 09/06/2006 | CN1827617A Antivirus use of 17-(tetrahydrofuryl-2'-yl) methyl amine-17-demethoxy geldanamycin |
| 09/06/2006 | CN1827616A Synthesis and uses of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole |
| 09/06/2006 | CN1827605A 4,4-disubstituted-3,4-dihydro-2(1H)- quinolones and synthesis process and use thereof |
| 09/06/2006 | CN1827604A Nitro compounds and their application in preparation of pemetrexed |
| 09/06/2006 | CN1827603A Novel pyrazole analogs acting on cannabinoid receptors |
| 09/06/2006 | CN1827602A Crystalline form gamma of the chlorhydrate of ivabradine, process for its preparation and phamaceutical composition containing it |
| 09/06/2006 | CN1827601A Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it |
| 09/06/2006 | CN1827600A Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharamcetuical composition containing it |
| 09/06/2006 | CN1827599A Crystalline form beta-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it |
| 09/06/2006 | CN1827590A Novel pregabalin crystalline form, its preparing process and pharmaceutical compositions thereof |
| 09/06/2006 | CN1827585A Non-crystalline memantine hydrochloride |
| 09/06/2006 | CN1827578A Anti-tumor naphthoquinone formic acid soft analogues |
| 09/06/2006 | CN1827171A Method for preparing capsaicin carrier |
| 09/06/2006 | CN1827170A Composition containing dihydropyridin type of calcium antagonists and fibrates medicine |
| 09/06/2006 | CN1827169A Composite preparation containing nitrate esters medicine and HMG-CoA reductase inhibitor |
| 09/06/2006 | CN1827167A Animal medicine capable of increasing immunologic function of livestock and birds |
| 09/06/2006 | CN1827166A Animal medicine for resisting and treating poultry coccidiosis |
| 09/06/2006 | CN1827165A Animal medicine capable of increasing weight of meat chicken |
| 09/06/2006 | CN1827164A Animal medicine capable of rehabilitating intestinal tract injury |
| 09/06/2006 | CN1827162A Animal medicine capable of resisting multiple irritated stress of chicken |
| 09/06/2006 | CN1827158A Compound forming agent with zedoary turmeric oil and method for preparing the same |
| 09/06/2006 | CN1827137A Blood-activating bone-resetting capsule |
| 09/06/2006 | CN1827133A Medicine for treating dermatopathy and its preparing process |
| 09/06/2006 | CN1827131A Medicinal composition for treating dysmenorrhea and preparation method thereof |
| 09/06/2006 | CN1827125A Compound orally disintegrating tablet of red sage root, its preparation method and quality control method |
| 09/06/2006 | CN1827117A Sustained release medicament of compound gossypol acetate |
| 09/06/2006 | CN1827116A First-class new medicine cyclovirobuxine D series for treating cardiovascular and cerebrovascular disease and method for preparing the same |
| 09/06/2006 | CN1827115A Film-coated tablet of glycyrrhizinic acid monopotassiium salt and method for preparing the same |
| 09/06/2006 | CN1827114A Pharmaceutical composition using efonidipine as active ingredient, its preparation method and use |
| 09/06/2006 | CN1827113A Pharmaceutical composition with anti-inflammation action |
| 09/06/2006 | CN1827112A Dispersion tablet for treating cardiovascular diseases and its preparation method |
| 09/06/2006 | CN1827111A Pharmaceutical composition using benazepril hydrochloride amlodipine besylate as active ingredients, its preparation method and use |
| 09/06/2006 | CN1827110A Pharmaceutical composition using hydrochlorothiazide and benazepril hydrochloride as active ingredients, its preparation method and use |
| 09/06/2006 | CN1827109A Lyophilized injection powder using Lanluodier and its salt as active ingredients and preparing technique therefor |
| 09/06/2006 | CN1827108A Use of cytosine derivative for preparing drug for treating cancer |
| 09/06/2006 | CN1827107A Substained analgesia achieved with buprenorphine |
| 09/06/2006 | CN1827106A Infusion bag with rabeprazole sodium injection and infusion liquor in isolated two chambers and preparation method thereof |
| 09/06/2006 | CN1827105A Foaming agent for treating gynecological disease and method for preparing the same |
| 09/06/2006 | CN1827104A Pharmaceutical compositions of levo-amlodipine and atorvastatin |
| 09/06/2006 | CN1827103A Pharmaceutical composition containing eprosartan, its preparation method and use |
| 09/06/2006 | CN1827102A Bilogical adhesive tablet of ornidazole and method for preparing the same |
| 09/06/2006 | CN1827101A Hemostatic injection of carbazochrome sodium sulfonate and method for preparing the same |
| 09/06/2006 | CN1827100A Pharmaceutical composition using ramatroban as active ingredient, its preparation method and use |
| 09/06/2006 | CN1827099A Intravenous administered injection of ginkgolide B, its preparation method and application |
| 09/06/2006 | CN1827098A Ipriflavone dispersed tablet and its preparation method |
| 09/06/2006 | CN1827097A Application of crocin-A in brain protection |
| 09/06/2006 | CN1827096A Docetaxel liposome containing chitosan derivative, lyophiled preparation and preparation method thereof |
| 09/06/2006 | CN1827095A Pharmaceutical composition using pregabalin as active ingredient, its preparation method and use |
| 09/06/2006 | CN1827094A Gel type dexketoprofen plaster and method for preparing the same |
| 09/06/2006 | CN1827093A Taurine injection and method for preparing the same |
| 09/06/2006 | CN1827092A Osmotic pump type controlled release preparation of tolterodine |
| 09/06/2006 | CN1827091A Medicinal composition containing backuchiol for treating female breast cancer |
| 09/06/2006 | CN1827090A Medicinal composition containing backuchiol for treating female osteoporosis |
| 09/06/2006 | CN1827087A Foaming agent of nonoxynol and method for preparing the same |
| 09/06/2006 | CN1827086A Foaming agent of povidone iodine and method for preparing the same |
| 09/06/2006 | CN1827084A Spot-removing skin-rehabilitating agent with gingseng, bamboo leaf and flavone for medical beautification |
| 09/06/2006 | CN1273608C Process for preparation of one or more inhibins by fermentation |
| 09/06/2006 | CN1273598C Bactericidal/permeability-increasing protein delation analogs |
| 09/06/2006 | CN1273496C Polysaccharose MF4 of mussel with enhancing immunity and anti-tumour activity |
| 09/06/2006 | CN1273495C Anti-tumor activating fuling scloerotium glucan sulfate and its preparation and use |
| 09/06/2006 | CN1273493C Angelica polysaccharide and its preparation and use |
| 09/06/2006 | CN1273492C Polysaccharide, preparation and use thereof |